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Hypertension is one of the most prevalent complications met within pregnancy and contributes significantly to maternal and perinatal morbidity and mortality [1]. 
Preeclampsia is a multisystem disorder of the mother that affects 
the fetus because of uteroplacental insufficiency [2]. These 
fetuses are at risk of intrauterine growth retardation, premature 
delivery, and other hematological disorders. Thrombocytopenia 
due to reduced platelet production is seen in the first 72 h of the 
life of these neonates [3-6]. Fortunately, most of these episodes 
are mild or moderate and resolve spontaneously [5].
The American College of Obstetrics and Gynecology defined 
that preeclampsia is the development of hypertension with 
proteinuria, edema or both, induced by pregnancy after 20 weeks 
of gestational and sometimes earlier when there are extensive 
hydatidiform changes in chorionic villi. Eclampsia is diagnosed 
when a patient with preeclampsia has convulsions in the absence 
of neurological disease [7]. In this study, an attempt has been 
made to evaluate the various maternal and neonatal factors 
associated with thrombocytopenia in a neonate born to mothers 
with pregnancy-induced hypertension (PIH).
METHODS
This observational study was conducted in the Department of 
Pediatrics, at a tertiary care institute during a period of 1 year, 
i.e., from April 2017 to March 2018. Ethical clearance and 
permission to conduct this study were taken from the institute’s 
ethical committee before the commencement of the study. Babies 
born to mothers with PIH were enrolled in the study. Perinatal 
data were collected after taking a detailed history from the 
mother or a close relative with respect to maternal age, pregnancy 
details, past medical history, antenatal visits, and examination 
details (blood pressure and presence of edema). Natal history 
was recorded as to the mode of delivery, presentation, placental 
anomaly or umbilical vessel anomaly, obstetric analgesia or 
anesthesia, birth trauma, and meconium stained liquor. Postnatal 
history was also recorded with regard to Apgar score at 1 and 
5 min, cry after birth, seizures, apnea, lethargy, and abnormal cry. 
Mother’s relevant investigations such as complete blood count, 
urine routine, blood urea, and liver function test were noted. 
All neonates were subjected to anthropometric examination 
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along with gestational age assessment and detailed general and 
systemic examinations.
Platelet count sampling was done in the labor room in all 
neonates born to PIH mother from cord blood or within the 1st h 
of life, subsequently 72 h and or on the 7th day of life if required. 
The low counts were confirmed manually using the Neubauer 
chamber. Platelet count of <150,000/mm3 was defined as 
thrombocytopenia. Platelet count of <50,000/mm3 with bleeding 
or <30,000/mm3 without bleeding was considered as severe 
thrombocytopenia [8,9]. Mothers with immune thrombocytopenia 
purpura and neonates with congenital anomalies and evidence 
of sepsis such as respiratory distress, lethargy, temperature 
instability, and seizure activity along with positive sepsis screen 
(leukopenia, neutropenia, positive C-reactive protein, and growth 
on blood culture) were excluded from the study along with those 
who refused to give consent for the study.
The above data were collected and tabulated using Microsoft 
Excel sheet. The data were then analyzed using SPSS software, 
Chi-square test and Fischer’s exact test were applied accordingly 
for statistical analysis.
RESULTS
A total of 181 cases of PIH were admitted during the study period; 
among those, 106 mothers were considered for the study due to 
their full follow-up from the birth of a baby to 7 days of life. A 
total of 111 babies was delivered from 106 mothers (5 pair of 
twin babies); out of them, 71 (63.96%) neonates had mothers 
with preeclampsia and 40 (36.04%) with eclampsia. There was no 
neonate with the mother having gestational hypertension. There 
were 65 (58.55%) neonates with primipara mothers as compared 
to 46 (41.55%) neonates with multipara mothers (Chi-square 
6.505, p=0.0107). In this study, mothers of 64 (57.65%) neonates 
developed symptoms and signs before 28 weeks of gestation while 
mothers of 47 (42.35%) developed later. 60 (54%) newborns had 
mothers who did not receive any antenatal medication (Table 1).
A total of 49 of these neonates were delivered normally while 
62 were delivered through lower segment cesarean section. 97 of 
these neonates (87.39%) had immediate cry after birth, 51.36% 
(57) were female, and 48.64% (54) were male with the male-
to-female ratio of 1:1.05. There were 70 (63.07%) term babies 
and 41 (36.93%) preterm babies in this study. Sixty-six (59.45%) 
of 111 neonates were low birth weight (LBW) babies. Most of 
these (88, 79.28%) neonates were appropriate for gestational age 
(AGA) as compared to 23 neonates (20.72%) who were small for 
gestational age (SGA). Seven of these babies were born to mothers 
who had taken antenatal treatment while 16 neonates were born 
from mothers who did not receive any antenatal care. Two of these 
111 neonates had head circumference and length of <3rd centile 
while the rest above 3rd centiles. In the present study, 59 (53.15%) 
neonates born to mothers with PIH had thrombocytopenia while 
12 (10.81%) had severe thrombocytopenia.
Table 1 represents a bivariate relationship of thrombocytopenia 
to various maternal characteristics. Thrombocytopenia was 
observed in 32 (28.83%) and 27 (24.33%) newborns of primi 
and multiparous women, respectively (p=0.3257). Severe 
thrombocytopenia in them was identical. A higher percentage 
of thrombocytopenia was observed with <28-week onset of 
symptoms, pre-eclamptic mothers, and untreated mothers, and 
these were not statistically significant. The occurrence of severe 
thrombocytopenia, i.e., 9 (8.1%) was found more in <28 weeks 
of the onset of PIH in comparison to 3 (2.7%) in >28 weeks of 
onset. Severe thrombocytopenia in the neonate of an eclamptic 
group 7 (6.30%) was more than pre-eclamptic group mothers 
babies. Severe thrombocytopenia was found in 6 neonates of each 
untreated as well as treated mothers. Maternal characteristics 
did not seem to be significantly associated with neonatal 
thrombocytopenia (p>0.05).
Thrombocytopenia was observed more in female 32 (28.83%) 
than in male 27 (24.32%). Furthermore, thrombocytopenia was 
observed more in <2.5 kg, term, AGA newborns. There were 
7 (6.30%) male babies with severe thrombocytopenia as compared 
to 5 (4.5%) female neonates. Severe thrombocytopenia was 5 times 
higher in LBW babies (9%) as compared to normal birth weight 
babies (9% vs. 1.8%). Percentage of severe thrombocytopenia 
in preterm infants was about 1.5 times higher than term infants 
(8.3% vs. 4.5%). Thrombocytopenia was significantly associated 
with LBW babies in this study (odds ratio [OR] - 1.8056; 95% 
confidence interval [CI]: 0.8395–3.8834; p=0.0305) and so was 
severe thrombocytopenia (OR 3.8393; 95% CI: 0.7993–18.442; 
p=0.0329). Severe thrombocytopenia was also significantly 
associated with birth weight versus gestational age (OR 7.2625; 
95% CI: 2.0471–25.7651; p=0.0004).
DISCUSSION
Severe hypertension in pregnant women is a multisystem disease 
and a threat to the well-being of both mother and child. Although 
the exact mechanism of action continues to be elusive, many 
factors may contribute to PIH such as abnormal trophoblast 
invasion, uteroplacental hypoperfusion, prostaglandin imbalance, 
endothelial dysfunction, inappropriate intravascular coagulation, 
and unexplained immunologic injury [7]. The presence of severe 
hypertension in pregnancy causes a marked imbalance in maternal 
homeostasis and unfavorable uterine environment for the fetus. 
The severity of uteroplacental insufficiencies experienced by 
these fetuses may be reflected in the low Apgar score, high 
hematocrit and increase in hemoglobin level, leucopenia, and 
thrombocytopenia [10].
This study was hence conducted in a tertiary care institute over 
a period of 1 year so as to evaluate neonatal thrombocytopenia 
in neonates of mothers with PIH and also to study the various 
maternal and neonatal factors associated with it. A total of 111 
neonates were included in the study with 5 pair of twin babies; 
out of them, 59 had thrombocytopenia with 12 (10.81%) having 
severe thrombocytopenia.
In this study, it was observed that 58.5% of neonates had 
primigravida mother. Derham and Hawkin and Prakash et al. 
observed that PIH was more common in primiparous mothers 
(57.64% and 57%, respectively) which is, however, lower than 
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as concluded by Pritchard et al. (85%) [11-13]. Primigravid 
condition is one of the high-risk factors for PIH. Its etiology 
is not clear but is proposed to occur due to dysfunction of the 
placental trophoblast and endothelial dysfunction with the 
maternal systemic vasculature [14]. The present study indicated 
that signs and symptoms of PIH appeared earlier that is at <28-
week gestation (57.65%) as compared to after 28 weeks. Mehta 
et al. a rural-based study reported significantly higher incidence 
with gestational period ≤20 weeks (10%) than with >20-
week gestational period (5.3%) [15]. In various hospital-based 
studies, the frequency was found to be higher after 28 weeks of 
gestation [12,16,17].
In our study, 88 (79.28%) newborns were AGA, 23 (20.22%) 
were SGA, and 59.45% were LBW babies. Higher incidence 
of somatic growth retardation, LBW, and prematurity in 
babies of PIH mothers have been perceived by other authors 
as well [2,10]. Compromised placental perfusion from uterine 
vasospasm is considered to be the most important causative 
factor for this. We observed thrombocytopenia in 53% neonates 
born to PIH mothers and 10.81% had severe thrombocytopenia. 
Bhat and Cherian demonstrated thrombocytopenia in 36% 
neonates born to PIH mothers with severe in 20% [18]. The 
combined effect of impaired megakaryocytic formation and 
increased platelet activation mediated through cytokines, 
thrombopoietin, and interleukin 6 was said to be most likely 
causative mechanisms [5,19].
A total of 32.43% of thrombocytopenic infants were born 
to pre-eclamptic mothers in our study while 22% in a study by 
Sivakumar et al. [20]. Raizada et al. also demonstrated that preterm 
infants born to pre-eclamptic mothers had thrombocytopenia; 
however, no significant correlation was found between the 
infants’ platelet count and severity of hypertension [21]. An 
incidence of up to 36% has been reported previously by other 
researchers [3,5,18,22].
LBW and prematurity were significantly associated with 
thrombocytopenia in our study. LBW infant was 5 times at 
increased risk of thrombocytopenia. Bhat and Cherian also 
reported 4.5 times increased risk of severe thrombocytopenia 
with decreasing birth weight while Roberts and Murray have 
proven that LBW infants are at 2.52 times increased risk for 
thrombocytopenia [4,18]. Tsao et al. concluded that birth weight 
is negatively associated with thrombocytopenia [19].
Prematurity was reported as another major risk linked with 
neonatal thrombocytopenia and maternal hypertension by many 
authors [6,10,22]. In our present study, premature newborns 
were at 1.5 times increased risk of severe thrombocytopenia 
compared to term infant. Previously, Bhat and Cherian inferred 
that premature infants were at 2.52 times increased the risk for 
Table 1: Bivariate relationship of thrombocytopenia to various maternal characteristics
Characteristic Total 
neonates (111)
Thrombocytopenia
Total (59) OR (95% CI) p-value Severe 12 OR (95% CI) p-value
Parity 0.6824 (0.3184–1.4623) 0.3257 0.9897 (0.2935–3.3366) 0.9866
Primipara 65 32 7
Multipara 46 27 5
Onset of PIH 0.9973 (0.4690–2.1210) 0.9945 2.4000 (0.6126–9.4022) 0.2089
<28 weeks 64 34 9
>28 weeks 47 25 3
Type of PIH 1.3154 (0.6026–2.8714) 0.4913 1.3061 (0.3858–4.4214) 0.661
Preeclampsia 71 36 5
Eclampsia 40 23 7
Medications 0.7353 (0.3474–1.5563) 0.4215 1.200 (0.3619–3.979) 0.7656
Yes 51 25 6
No 60 34 6
Sex 0.7813 (0.3701–0.6492) 0.5173 0.15489 (0.4602–5.2219) 0.4797
Male 54 27 7
Female 57 32 5
Birth weight 1.8056 (0.8395–3.8834) 0.0305 3.8393 (0.7993–18.442) 0.0329
<2500 g 66 39 10
>2500 g 45 20 2
Gestational age 1.6544 (0.7559–3.6208) 0.2077 2.6765 (0.7899–9.0687) 0.1138
<37 weeks 41 25 7
>37 weeks 70 34 5
Birth weight versus 
gestational age
1.8056 (0.8395–3.8834) 0.2077
7
7.2626 (2.0471–25.7651) 0.0021
SGA 23 17
AGA 88 42 5
SGA: Small for gestational age, AGA: Appropriate for gestational age, PIH: Pregnancy-induced hypertension, CI: Confidence interval, OR: Odd ratio
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severe thrombocytopenia compared to term infant [18]. The risk 
of thrombocytopenia was not found to be different in SGA or AGA 
newborns. However, in the present study, severe thrombocytopenia 
was significantly associated with SGA babies. Sola et al. 
observed that premature neonates are more prone to develop 
thrombocytopenia as compared to their term counterparts [23].
This study is restricted by its small sample size. Furthermore, 
the frequency of thrombocytopenia due to other causes was not 
compared to neonates born to PIH mothers. Platelet transfusion 
requirement and outcome of these newborns were also not 
analyzed in this study.
CONCLUSION
In this study, we infer that LBW and premature newborns born 
to mothers with PIH are prone to severe thrombocytopenia and 
require scrutiny during the 1st week of life.
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